Balchem Corporation (BCPC): Price and Financial Metrics
Balchem Corporation (BCPC)
Today's Latest Price: $99.95 USD
Updated Oct 30 4:00pm
Add BCPC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BCPC Stock Summary
- BCPC's went public 34.44 years ago, making it older than 92.69% of listed US stocks we're tracking.
- Price to trailing twelve month operating cash flow for BCPC is currently 23.86, higher than 83.86% of US stocks with positive operating cash flow.
- In terms of volatility of its share price, BCPC is more volatile than merely 1.51% of stocks we're observing.
- Stocks that are quantitatively similar to BCPC, based on their financial statements, market capitalization, and price volatility, are NVRO, HVT, FDS, KRG, and HUBS.
- BCPC's SEC filings can be seen here. And to visit Balchem Corp's official web site, go to www.balchem.com.
BCPC Stock Price Chart Interactive Chart >
BCPC Price/Volume Stats
| Current price | $99.95 | 52-week high | $113.93 |
| Prev. close | $100.24 | 52-week low | $78.30 |
| Day low | $98.39 | Volume | 92,900 |
| Day high | $100.07 | Avg. volume | 133,249 |
| 50-day MA | $99.53 | Dividend yield | 0.52% |
| 200-day MA | $98.09 | Market Cap | 3.23B |
Balchem Corporation (BCPC) Company Bio
Balchem Corporation consists of four business segments: ARC Specialty Products, SensoryEffects (formerly Food, Pharma and Nutrition), Animal Nutrition & Health, and Industrial Products. Through ARC Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries. The company was founded in 1967 and is based in New Hampton, New York.
BCPC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $99.95 | $44.25 | -57% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Balchem Corp. To summarize, we found that Balchem Corp ranked in the 28th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Balchem Corp ended up being:
- The company's balance sheet shows it gets 94% of its capital from equity, and 6% of its capital from debt. Its equity weight surpasses that of 86.91% of free cash flow generating stocks in the Basic Materials sector.
- The business' balance sheet suggests that 6% of the company's capital is sourced from debt; this is greater than just 16.89% of the free cash flow producing stocks we're observing.
- BCPC's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 41.87% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -58% |
| 1% | -57% |
| 2% | -57% |
| 3% | -57% |
| 4% | -56% |
| 5% | -56% |
Want more companies with a valuation profile/forecast similar to that of Balchem Corp? See SYNL, GRA, ARLP, AUY, and CPAC.
Loading social stream, please wait...